English
简体中文
Total: £ 56.28
2025-06-24 | Pages: 108 | Tables: 114
The global market for Purvalanol A (CDK Inhibitor) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.Purvalanol A is a cell-permeable, potent, ...
2025-06-24 | Pages: 98 | Tables: 98
The global market for Semagacestat was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.Semagacestat is an inhibitor of the γ-secretase complex. I...
2025-06-24 | Pages: 95 | Tables: 95
The global market for 1-Acetyl-2-Phenylhydrazine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.1-Acetyl-2-Phenylhydrazine(CAS 114-83-0) whi...
2025-06-24 | Pages: 90 | Tables: 86
The global market for Ferric Stearate was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.Ferric stearate(CAS 555-36-2) is an orange-red compound...
2025-06-24 | Pages: 98 | Tables: 105
The global market for Benzyl Azide was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.Benzyl azide is an aromatic azide generally used in copper...
2025-06-24 | Pages: 105 | Tables: 104
The global market for L-Ascorbic Acid 6-Palmitate was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period. L-Ascorbic Acid 6-Palmitate is a lipid so...
2025-06-24 | Pages: 99 | Tables: 96
The global market for Propargyl Ether was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.The Propargyl ether molecule consists of 6 Hydrogen ato...
2025-06-24 | Pages: 105 | Tables: 103
The global market for Propargylamine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.Propargylamine is water, chloroform, and ethyl acetate m...
2025-06-24 | Pages: 113 | Tables: 108
The global market for Avagacestat was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.Avagacestat is an oral gamma secretase inhibitor designed f...
2025-06-24 | Pages: 117 | Tables: 123
The global market for Staurosporine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.Staurosporine is a small molecule. Staurosporine is a bro...
2025-06-24 | Pages: 95 | Tables: 88
The global market for Inorganic Pyrophosphatase was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.Inorganic Pyrophosphatase is an enzyme that c...
2025-06-24 | Pages: 111 | Tables: 113
The global market for Blasticidin S was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.Blasticidin S is a peptide nucleoside antibiotic that is ...
2025-06-24 | Pages: 99 | Tables: 103
The global market for Evacetrapib was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.Evacetrapib is a cholesterol ester transfer protein inhibit...
2025-06-24 | Pages: 112 | Tables: 110
The global market for Dalcetrapib was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.Dalcetrapib is a CETP inhibitor.Inhibition of CETP is a tar...
2025-06-24 | Pages: 102 | Tables: 98
The global market for Anacetrapib was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.Anacetrapib is a CETP inhibitor being developed to treat hy...
